Marksans Pharma Ltd Half Yearly Results

Gross Sales

1,390.3

1,232.54

1,146.14

1,031.27

965.81

Excise Duty

0

0

0

0

0

Net Sales

1,390.3

1,232.54

1,146.14

1,031.27

965.81

Other Operating Income

0

0

0

0

0

Other Income

44.37

26.01

21.33

29.09

28.66

Total Income

1,434.67

1,258.55

1,167.47

1,060.36

994.47

Total Expenditure

1,125.79

968.42

903.48

815.35

779.61

PBIDT

308.89

290.13

263.99

245.01

214.85

Interest

6.1

5.56

8

3.2

4.79

PBDT

302.79

284.57

255.99

241.81

210.06

Depreciation

43.43

39.95

43.06

31.21

26.69

Minority Interest Before NP

0

0

0

0

0

Tax

62.29

66.3

58.81

54.93

36.3

Deferred Tax

1.27

-8.51

-6.48

1.38

2.06

Reported Profit After Tax

195.79

186.83

160.61

154.29

145.02

Minority Interest After NP

0.69

1.36

-0.92

2.11

-0.32

Net Profit after Minority Interest

195.11

185.47

161.52

152.18

145.34

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

195.11

185.47

161.52

152.18

145.34

EPS (Unit Curr.)

4.31

4.09

3.56

3.36

3.21

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

45.32

45.32

45.32

45.32

45.32

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.21

23.53

23.03

23.75

22.24

PBDTM(%)

-

-

-

-

-

PATM(%)

14.08

15.15

14.01

14.96

15.01